Related Experiment Video
Updated: Feb 8, 2026

An Iodide-Yellow Fluorescent Protein-Gap Junction-Intercellular Communication Assay
Published on: February 1, 2019
Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe
Florian Douam1, Alexander Ploss1
1Department of Molecular Biology, Princeton University, 110 Lewis Thomas Laboratory, Washington Road, Princeton, NJ 08544, USA.
Abstract:
Yellow fever (YF) was one of the most dangerous infectious diseases of the 18th and 19th centuries, resulting in mass casualties in Africa and the Americas. The etiologic agent is yellow fever virus (YFV), and its live-attenuated form, YFV-17D, remains one of the most potent vaccines ever developed. During the first half of the 20th century, vaccination combined with mosquito control eradicated YFV transmission in urban areas. However, the recent 2016-2018 outbreaks in areas with historically low or no YFV activity have raised serious concerns for an estimated 400-500 million unvaccinated people who now live in at-risk areas. Once a forgotten disease, we highlight here that YF still represents a very real threat to human health and economies. As many gaps remain in our understanding of how YFV interacts with the human host and causes disease, there is an urgent need to address these knowledge gaps and propel YFV research forward.
Insights
Yellow fever (YF) remains a significant global health threat, despite historical control. Recent outbreaks highlight the urgent need for research into yellow fever virus (YFV) and host interactions.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Yellow fever (YF) historically caused devastating epidemics in Africa and the Americas.
- The live-attenuated YFV-17D vaccine is highly effective.
- Urban YF transmission was largely controlled in the 20th century through vaccination and mosquito control.
Observation:
- Recent YF outbreaks (2016-2018) occurred in areas with previously low disease activity.
- An estimated 400-500 million unvaccinated individuals reside in current at-risk regions.
- YF poses a renewed threat to human health and economic stability.
Findings:
- Yellow fever virus (YFV) research has significant knowledge gaps regarding host-pathogen interactions and disease mechanisms.
- The YFV-17D vaccine's long-term efficacy and safety in evolving epidemiological contexts require ongoing evaluation.
- Understanding YFV pathogenesis is crucial for predicting and managing future outbreaks.
Implications:
- There is an urgent need to advance YFV research to address current knowledge gaps.
- Enhanced surveillance and vaccination strategies are necessary for at-risk populations.
- Continued investment in YF research is vital for global health security and economic resilience.
More Related Videos
09:13Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
08:33A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti
Published on: May 16, 2011
Related Concept Videos
Types of Fever
Here are the different types of fever:
Patterns of Fever
Gap Junctions
Gap Junctions
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
What are Viruses?